How do I convert a daily dose of isosorbide mononitrate to an equivalent daily dose of isosorbide dinitrate and divide it into three equal administrations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Isosorbide Mononitrate to Dinitrate Dose Conversion

There is no established, evidence-based conversion ratio between isosorbide mononitrate and isosorbide dinitrate, but based on FDA-approved dosing and clinical pharmacology, a practical approach is to use approximately 2:1 ratio (dinitrate:mononitrate) when converting total daily doses, then divide the dinitrate dose into three equal administrations.

Conversion Approach

Step 1: Calculate Equivalent Total Daily Dose

The most reasonable conversion uses approximately 2:1 ratio based on the following evidence:

  • Isosorbide mononitrate (the active metabolite): FDA-approved dosing ranges from 30-240 mg once daily 1
  • Isosorbide dinitrate: FDA-approved dosing is 20-30 mg three to four times daily, with maximum 120 mg/day 2

Practical conversion formula:

  • If patient takes 60 mg mononitrate once daily → convert to 120 mg dinitrate total daily (divided into three 40 mg doses)
  • If patient takes 120 mg mononitrate once daily → this approaches the maximum dinitrate dose of 120 mg/day total

Step 2: Divide Into Three Equal Doses

Isosorbide dinitrate must be given 3-4 times daily to maintain therapeutic effect 2, 3, 4. The standard regimen is:

  • Starting dose: 20-30 mg three times daily
  • Target dose: 40 mg three times daily (120 mg total)
  • Timing: Administer at regular intervals throughout waking hours

Key Clinical Considerations

Why This Conversion Is Imprecise

The pharmacokinetics differ substantially between these compounds 1:

  • Mononitrate has ~100% bioavailability, no first-pass metabolism, and 5-hour half-life
  • Dinitrate undergoes extensive first-pass metabolism to mononitrate and has variable bioavailability
  • Dinitrate is essentially a prodrug that converts to mononitrate 1

Research comparing these agents shows similar efficacy at seemingly disparate doses. Studies found 60 mg mononitrate once daily comparable to 60 mg dinitrate total daily (20 mg three times daily) 5, 6, suggesting closer to 1:1 equivalence in some contexts, while other data support the 2:1 ratio used in heart failure guidelines 3, 4, 3.

Tolerance Prevention

Both formulations develop tolerance with continuous exposure 1. The key difference:

  • Mononitrate once daily provides a built-in nitrate-free interval overnight, reducing tolerance risk
  • Dinitrate three times daily maintains more continuous exposure, potentially accelerating tolerance

When converting, maintain the last dose no later than early evening to preserve a nitrate-free interval of at least 10-12 hours overnight.

Dosing Algorithm

For conversion from mononitrate to dinitrate:

  1. If on 30-60 mg mononitrate daily: Start dinitrate 20 mg three times daily (60 mg total)
  2. If on 120 mg mononitrate daily: Start dinitrate 30-40 mg three times daily (90-120 mg total)
  3. Maximum dinitrate dose: 40 mg three times daily (120 mg total) 3, 4, 3

Common Pitfalls

  • Do not exceed 120 mg total daily dinitrate - this is the evidence-based maximum for heart failure 3, 4, 3
  • Do not give dinitrate once or twice daily - this defeats the purpose of conversion and risks inadequate coverage
  • Monitor for increased headache - dinitrate's multiple daily doses may cause more frequent nitrate-related headaches initially
  • Watch for hypotension - the more frequent dosing can cause cumulative hemodynamic effects

When Conversion Makes Sense

The primary reason to convert from mononitrate to dinitrate is for use in heart failure with reduced ejection fraction, particularly in African American patients, where the fixed-dose combination with hydralazine (BiDil: 20-40 mg isosorbide dinitrate with 37.5-75 mg hydralazine three times daily) has proven mortality benefit 3, 4, 3.

For angina alone, mononitrate once daily is generally preferable due to better compliance, built-in tolerance prevention, and equivalent efficacy 5, 6, 7.

Related Questions

What are the differences between isosorbide mononitrate and isosorbide dinitrate?
For chronic prophylaxis of angina, which is preferred: isosorbide mononitrate or isosorbide dinitrate?
What are the recommended starting and maximum doses for oral isosorbide dinitrate and isosorbide mononitrate?
Is Imdur (isosorbide mononitrate) a short‑acting nitrate?
What is the appropriate immediate‑release (IR) isosorbide mononitrate dose equivalent to 30 mg extended‑release (ER) for a patient who requires the medication to be crushed?
What are the five most prescribed antimalarial agents and the geographic regions where each is active?
Which antimalarial agents are most commonly prescribed in Canada for prophylaxis and treatment, and in which endemic regions do they remain effective?
As a healthcare provider evaluating patients traveling to Spain, what specific communicable diseases and assessments must I review to certify, per the International Health Regulations (2005), that they do not have any condition that could cause serious public‑health repercussions?
If a patient has been on oral aripiprazole for two weeks and is tolerating it well, can I order the aripiprazole long‑acting injectable (LAI) now and administer it at the four‑week visit, maintaining the required 14‑day oral overlap?
What is the recommended erythromycin dosing regimen for adults and children, including route, dose, frequency, duration, and adjustments for hepatic impairment?
What are the recommended NSAID choices and gastro‑protective strategies for a patient with dyspepsia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.